British Growth Fund

Doctor sitting down and holding a model of a liver
BGF exits Oxford medtech OrganOx in $1.5B deal
By Jessica Hagen | 12:57 pm | August 25, 2025
British Growth Fund’s exit marks one of the largest for a UK medtech company and the most profitable return in the firm’s history.